Catalyst Pharmaceuticals (CPRX) Reaches $2.65 After 4.00% Up Move; Astronova (ALOT) Shorts Decreased By 71.19%

June 21, 2017 - By marketbeat

The stock of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) is a huge mover today! About 495,222 shares traded. Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) has risen 267.48% since June 21, 2016 and is uptrending. It has outperformed by 250.78% the S&P500.The move comes after 6 months positive chart setup for the $235.48 million company. It was reported on Jun, 21 by Barchart.com. We have $2.76 PT which if reached, will make NASDAQ:CPRX worth $9.42 million more.

Astronova Incorporated (NASDAQ:ALOT) had a decrease of 71.19% in short interest. ALOT’s SI was 7,000 shares in June as released by FINRA. Its down 71.19% from 24,300 shares previously. With 14,000 avg volume, 1 days are for Astronova Incorporated (NASDAQ:ALOT)’s short sellers to cover ALOT’s short positions. The SI to Astronova Incorporated’s float is 0.12%. About 300 shares traded. AstroNova Inc (NASDAQ:ALOT) has declined 1.05% since June 21, 2016 and is downtrending. It has underperformed by 17.75% the S&P500.

Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., is a development-stage biopharmaceutical company. The company has market cap of $235.48 million. The Firm is focused on developing and commercializing therapies for people with rare debilitating diseases. It currently has negative earnings. The Firm has three drugs in development: Firdapse, CPP-109 and CPP-115.

Among 2 analysts covering Catalyst Pharmaceuticals (NASDAQ:CPRX), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Catalyst Pharmaceuticals had 3 analyst reports since April 26, 2016 according to SRatingsIntel. The stock of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) has “Overweight” rating given on Wednesday, October 5 by Piper Jaffray. As per Wednesday, October 5, the company rating was upgraded by PiperJaffray. The stock of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) has “Neutral” rating given on Tuesday, April 26 by Piper Jaffray.

Investors sentiment increased to 0.94 in Q4 2016. Its up 0.64, from 0.3 in 2016Q3. It increased, as 6 investors sold Catalyst Pharmaceuticals Inc shares while 12 reduced holdings. 9 funds opened positions while 8 raised stakes. 23.81 million shares or 1.65% more from 23.42 million shares in 2016Q3 were reported. Oxford Asset Mngmt has invested 0% in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX). Millennium Ltd Llc has invested 0% in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX). Provise Mngmt Grp Limited reported 0% stake. D E Shaw Inc reported 12,651 shares or 0% of all its holdings. 63,300 are owned by Art Advsrs Ltd Liability Corporation. Vanguard Group Inc invested in 2.99 million shares. Agran Libbie reported 0.01% stake. New York-based Baker Bros Advsrs L P has invested 0.05% in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX). Fincl Bank Of Montreal Can has 0% invested in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX). 469,440 are held by Blackrock Institutional Tru Company Na. Northern Trust invested 0% of its portfolio in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX). Weiss Multi stated it has 0% in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX). State Street Corp owns 45,300 shares. 8,097 were accumulated by Tower Rech Ltd Liability Company (Trc). Commonwealth Equity has 24,000 shares for 0% of their portfolio.

Investors sentiment increased to 1.38 in Q4 2016. Its up 0.56, from 0.82 in 2016Q3. It increased, as 1 investors sold AstroNova Inc shares while 7 reduced holdings. 2 funds opened positions while 9 raised stakes. 3.52 million shares or 3.53% more from 3.40 million shares in 2016Q3 were reported. Wells Fargo Mn accumulated 1 shares. Commonwealth Equity has invested 0% in AstroNova Inc (NASDAQ:ALOT). Girard Ptnrs Limited reported 0.08% stake. Vanguard Group holds 0% or 122,349 shares in its portfolio. Northern Tru Corporation reported 0% stake. Grace & White New York holds 108,086 shares or 0.33% of its portfolio. Parkside Retail Bank Tru holds 854 shares or 0.01% of its portfolio. Blackrock Fund has invested 0% in AstroNova Inc (NASDAQ:ALOT). Rutabaga Capital Mgmt Limited Liability Co Ma owns 551,836 shares. Ariel Investments invested 0.15% in AstroNova Inc (NASDAQ:ALOT). North Star Inv Corporation, Illinois-based fund reported 53,487 shares. Bankshares Of New York Mellon invested in 11,438 shares. Morgan Stanley reported 4,831 shares. Financial Bank Of America De has 0% invested in AstroNova Inc (NASDAQ:ALOT). Bridgeway Capital holds 34,000 shares or 0.01% of its portfolio.

Since March 20, 2017, it had 0 insider buys, and 3 insider sales for $11.28 million activity. Albert W. Ondis Declaration of Trust also sold $11.24 million worth of AstroNova Inc (NASDAQ:ALOT) shares. Shares for $23,606 were sold by Natalizia Michael J. Shares for $23,577 were sold by Pizzuti Eric E.